Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myeloid Leukemia
50%
Epigenetic Reprogramming
50%
Epigenetics
29%
Epigenomics
28%
Advanced Solid Tumors
25%
Cancer Patients
25%
Undifferentiated Pleomorphic Sarcoma
25%
Tumor Cell Subpopulations
25%
Phase I Trial
25%
Potential Biomarkers
25%
Drug Target
25%
Bivalent Chromatin
25%
Biomarkers of Response
25%
Ovarian Cancer
25%
PTGIS
25%
T Cells
25%
Cancer Immunotherapy
25%
IACS-010759
25%
Oxidative Phosphorylation (OXPHOS)
25%
Epigenetic Drugs
25%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
25%
Complex I Inhibitors
25%
Antigen Identification
25%
Synapse
25%
H3K27 Acetylation
25%
Colorectal Cancer
25%
5-azacytidine
25%
BRAF V600E
25%
H3K4 Methylation
25%
DNA Methylation (DNAm)
25%
Resistance Mechanisms
25%
Natural Killer Cells
25%
Enhancer Reprogramming
25%
Epigenetic Modification
24%
Tumor
23%
Gene Expression
20%
Curcumin
16%
Tumor Progression
16%
5-Aza-dC
16%
Residual Tumor
16%
Complementary DNA (cDNA)
15%
T Cell Receptor
15%
Sarcoma
15%
Heterogeneity in Responses
12%
Tumor Immune Microenvironment
12%
Immuno-oncology
12%
Disease-related
12%
Reoccurrence
12%
NewHope
12%
Immune-related Adverse Effects
12%
Biochemistry, Genetics and Molecular Biology
Reprogramming
100%
Enhancer Region
77%
Epigenetics
58%
Epigenome
38%
DNA Methylation
30%
Drug Targeting
25%
DNA Condensation
25%
Bivalent Chromatin
25%
Alpha Thalassemia/Mental Retardation X-Linked
25%
Dynamics
25%
T Cell
25%
Cytotype
25%
Sirtuin
25%
Arginine
25%
Lysine
25%
Gene Targeting
25%
KEAP1
25%
Synapse
25%
Cisplatin
25%
Azacitidine
25%
SMARCA2
25%
SMARCA4
25%
Growth Factor
25%
Tumor Progression
23%
Gene Expression
18%
T Cell Receptor
15%
DNA Library
15%
Metabolic Pathway
14%
Mouse Model
14%
Carcinogenesis
12%
Tumor Suppressor Protein
11%
Histone Modification
11%
Cancer Cell
11%
Transcriptomics
10%
Promoter Region
10%
Human Papillomavirus Type 16
10%
Chromatin Remodeling
8%
Glutaminase
8%
Wild Type
8%
Glutamine
8%
Western Blot
8%
Nude Mouse
8%
Immunostaining
8%
Transfection
8%
Exome Sequencing
8%
Clonal Evolution
8%
Aggression
8%
Genetics
8%
DNA Methyltransferase
7%
EZH2
7%
Medicine and Dentistry
Neoplasm
52%
Tumor Cell
35%
Head and Neck Squamous Cell Carcinoma
25%
Drug Response
25%
Drug Delivery System
25%
Malignant Peripheral Nerve Sheath Tumor
25%
Cisplatin
25%
Biological Marker
25%
Connective Tissue Cancer
25%
Ovarian Cancer
25%
Metastatic Carcinoma
25%
Acute Myeloid Leukemia
25%
Natural Killer Cell
25%
Cell Line
15%
In Vitro
15%
Distant Metastasis
15%
Tumor Progression
13%
Gene Expression
12%
Tumour Heterogeneity
10%
Drug Efficacy
9%
Drug Screening
9%
Curcumin
8%
Myeloid Malignancy
8%
Transcriptomics
7%
Cellular Model
6%
Subcutaneous Injection
6%
Implant
6%
Xenograft
6%
Glutaminase
5%
Exome Sequencing
5%
Western Blot
5%
Cancer Therapy
5%
Flow Cytometry
5%
Health Care Cost
5%
Cell Heterogeneity
5%
Head and Neck Tumor
5%
Cancer Stem Cell
5%
Immunohistochemistry
5%
Target Identification
5%
Tongue
5%
Glutamine
5%
NRF2/KEAP1 Pathway
5%
Drug Repositioning
5%
Oral Cancer
5%
Cell Signaling Pathway
5%
Head and Neck Squamous Cell Carcinoma Cell Line
5%
Aggression
5%
Squamous Cell Carcinoma Cell
5%
